← Volver al sitio

Publicaciones

57 artículos publicados · 1 en revisión

Lista completa de publicaciones del grupo y de su director, Dr. Darío Fernández Do Porto (resaltado en negrita), ordenadas por año.

En revisión

  1. Genomic Characterization of Extensively Drug-Resistant (XDR) Klebsiella pneumoniae from Ecuador Isolates Co-harboring blaKPC and blaNDM genes and Exhibiting Chromosomal Colistin Resistance

    Gaibor-Verdezoto J, Fuertes-Flores B, Ortega-Paredes D, …, Fernandez Do Porto D. BMC Infectious Diseases (en revisión).

2026

  1. Metabolic plasticity under iron limitation reveals a tryptophan-derived melanin in Pseudomonas aeruginosa

    Diaz Appella MN, Kolender AA, Nega M, …, Fernández Do Porto DA, …, Tribelli P. mSystems, 2026.

  3. Burkholderia vietnamiensis Genes Involved in Extracellular Medium-Chain-Length Polyhydroxyalkanoate Degradation

    Yap ZL, Yi S, Quintana E, …, Fernández Do Porto D, Levin D, Cardona S. Applied and Environmental Microbiology, 2026.

2025

  1. Beyond Tanimoto: A Learned Bioactivity Similarity Index Enhances Ligand Discovery

    Schottlender G, Prieto JM, Martí MA, Fernández Do Porto D. Frontiers in Bioinformatics, 2025.

  2. Genomic Characterization of XDR Mycobacterium tuberculosis Isolates in Argentina (2006–2015)

    Castello FA, Sosa EJ, Campos J, …, Martí M, Fernández Do Porto D. BMC Infectious Diseases, 2025.

  4. PAPreC: A Comprehensive Pipeline for Comparing Antigenicity Prediction and Assessing Factors Influencing Predictive Performance

    Martins Y, Cerqueira e Costa M, Palumbo M, Fernández Do Porto D, Custódio FL, Trevizani R, Nicolás M. ACS Omega, 2025.

  5. Genomic, socio-environmental, and sequencing capability patterns in the surveillance of SARS-CoV-2 in Latin America and the Caribbean up to 2023

    Concha-Toloza M, Collado González L, Herrera Estrella A, Fernández Do Porto D, Campos Sánchez R, Molina Mora JA. Scientific Reports, 2025.

  6. Virological Characterization of a New Isolated Strain of Andes Virus Involved in the Recent Person-to-Person Transmission Outbreak Reported in Argentina

    Coelho RM, Kehl S, Periolo N, …, Fernández Do Porto D, …, Martinez VP. PLOS Neglected Tropical Diseases, 2025.

  7. Expanding kinetoplastid genome annotation through protein structure comparison

    Trinidad-Barnech JM, Sotelo-Silveira J, Fernández Do Porto D, Smircich P. PLOS Pathogens, 2025.

  8. Genome characterization of Enterococcus lactis strain isolated from bovine subclinical mastitis

    Moliva M, Fernández F, Cerioli M, Serral F, Fernández Do Porto D, Reinoso E. Microbial Pathogenesis, 2025.

  9. Phage PL-1 Endolysin and Osmotic Stress as Tools to Enhance Heterologous Protein Display in Lactic Acid Bacteria Platform

    Gordillo TB, Jastrebow IG, De Rossi C, …, Fernández Do Porto DA, Palomino MM. International Journal of Biological Macromolecules, 2025.

  10. Burkholderia Genes Involved in Extracellular Bioplastic Degradation Revealed by Tn-seq and CRISPR-Cas (preprint)

    Yap ZL, Lucas GG, Safklou M, …, Fernández Do Porto D, Cardona S. bioRxiv, 2025.

  11. Genomic analysis and virulence features of environmental Vibrio cholerae non-O1/non-O139 harboring CARB-type beta-lactamases

    Guevara Núñez D, Morandini FN, Suleyman G, …, Fernández Do Porto D, Zervos M, Sola C, Saka HA. Environmental Microbiology Reports, 2025.

2024

  1. High-throughput prioritization of target proteins for development of new antileishmanial compounds

    Azevedo LG, Queiroz A, Barral A, …, Sosa EJ, Fernández Do Porto D, Pereira Ramos PI. Frontiers in Pharmacology, 2024.

  2. Fever-like temperature impacts on Staphylococcus aureus and Pseudomonas aeruginosa interaction, physiology, and virulence both in vitro and in vivo

    Solar Venero EC, Galeano MB, Luqman A, …, Fernandez Do Porto D, …, Götz F, Tribelli PM. BMC Microbiology, 2024.

  3. Nitrosative stress under microaerobic conditions triggers inositol metabolism in Pseudomonas extremaustralis

    Solar Venero EC, Giambartolomei L, Sosa E, Fernández Do Porto D, López NI, Tribelli PM. PLOS ONE, 2024.

2023

  1. Bacterial Cytochrome P450s: A Bioinformatics Odyssey of Substrate Discovery

    Schottlender G, Prieto JM, Clemente C, Schuster CD, Dumas V, Fernández Do Porto D, Martí MA. Frontiers in Microbiology, 2023.

  2. Omics data integration facilitates drug target selection for new antiparasitics against trypanosomatid infections

    Rivara-Espasandin M, Palumbo M, Sosa EJ, Radio S, Turjanski A, Sotelo Silveira J, Fernández Do Porto D, Smircich P. Frontiers in Pharmacology, 2023.

  3. Overview of the SARS-CoV-2 genotypes circulating in Latin America during 2021

    Molina-Mora JA, Reales-González J, Camacho E, …, Fernández Do Porto DA, …, Herrera Estrella A. Frontiers in Public Health, 2023.

  4. The Lambda Variant in Argentina: Analyzing the Evolution and Spread of SARS-CoV-2 Lineage C.37

    Nabaes Jodar MS, Goya S, Valinotto LE, …, Viegas M (Proyecto PAIS; miembro del consorcio: Fernández Do Porto D). Viruses, 2023.

  5. Assessing the hidden diversity underlying consensus sequences of SARS-CoV-2 using VICOS, a novel bioinformatic pipeline for identification of mixed viral populations

    Goya S, Sosa E, Nabaes Jodar M, …, Fernández Do Porto D, …, Aulicino P, Viegas M. Virus Research, 2023.

  6. Genetic dissection of the degradation pathways for the mycotoxin fusaric acid in Burkholderia ambifaria T16

    Vinacour M, Moiana M, Forné I, …, Palumbo M, Fernández Do Porto D, Imhof A, Ruiz J. Applied and Environmental Microbiology, 2023.

  7. Persistence of SARS-CoV-2 RNA shedding and infectivity in immunized population: prospective study along different epidemiological periods in Argentina

    Torres C, Nabaes Jodar M, Acuña D, …, Proyecto PAIS (miembro del consorcio: Fernández Do Porto D). Viruses, 2023.

  8. Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5

    Torres C, Nabaes Jodar M, Acuña D, …, Proyecto PAIS (miembro del consorcio: Fernández Do Porto D), Valinotto L, Viegas M. Viruses, 2023.

  9. Genome sequence and characterization of a hypervirulent BI/NAP1/027 Clostridioides difficile (CDC20121308) (preprint)

    Español LA, Palumbo MC, Barbero AM, …, Marti MA, Fernández Do Porto D, Hernández Del Pino RE, Pasquinelli V. bioRxiv, 2023.

2022

  1. From Drugs to Targets: Reverse engineering the virtual screening process on a proteomic scale

    Schottlender G, Prieto JM, Palumbo M, Sosa E, Castello F, Serral F, Turjanski A, Marti M, Fernández Do Porto D. Frontiers in Drug Discovery, 2022.

  2. Integrating diverse layers of omic data to identify novel drug targets in Listeria monocytogenes

    Palumbo M, Sosa E, Castello F, Schottlender G, Serral F, Turjanski A, Palomino MM, Fernández Do Porto D. Frontiers in Drug Discovery, 2022.

  3. Pathway-driven target selection in carbapenem-resistant Klebsiella pneumoniae

    Serral F, Pardo A, Sosa EJ, Palomino MM, Nicolás MF, Turjanski AG, Pereira Ramos PI, Fernández Do Porto D. Frontiers in Cellular and Infection Microbiology, 2022.

  4. Spatial and seasonal variations in the bacterial community of an anthropogenic impacted urban stream

    Vignale FA, Bernal Rey D, Pardo AM, …, Fernández Do Porto D, Turjanski AG, López NI, Menéndez Helman RJ, Raiger Iustman LJ. Microbial Ecology, 2022.

  5. Genome mining of Burkholderia ambifaria strain T16, a rhizobacterium able to produce antimicrobial compounds and degrade the mycotoxin fusaric acid

    Alvarez F, Simonetti E, Draghi WO, Vinacour M, Palumbo MC, Fernández Do Porto D, Montecchia MS, Roberts IN, Ruiz J. World Journal of Microbiology and Biotechnology, 2022.

  6. Selecting putative drought-tolerance markers in two contrasting soybeans

    Toum L, Pérez-Borroto LS, Peña-Malavera AN, …, Berenstein A, Fernández Do Porto D, Vojnov A, Castagnaro A, Pardo EM. Scientific Reports, 2022.

2021

  1. Five-year microevolution of a multidrug-resistant Mycobacterium tuberculosis strain within a patient with inadequate compliance to treatment

    Fernández Do Porto DA, Monteserin J, Campos J, Sosa EJ, …, Turjanski A, Ritacco V. BMC Infectious Diseases, 2021.

  2. From genome to drugs: New approaches in antimicrobial discovery

    Serral F, Castello FA, Sosa EJ, Pardo AM, Palumbo MC, Modenutti C, Palomino MM, Lazarowski A, Auzmendi JA, Pereira Ramos PI, Nicolás MF, Turjanski AG, Martí MA, Fernández Do Porto D. Frontiers in Pharmacology, 2021.

  3. Identification of potential kinase inhibitors within the PI3K/AKT pathway of Leishmania species

    Ochoa R, Ortega-Pajares A, Castello FA, Serral F, Fernández Do Porto D, Villa-Pulgarín JA, Varela-M RE, Muskus C. Biomolecules, 2021.

  4. Cost-Effective Method to Perform SARS-CoV-2 Variant Surveillance: Detection of Alpha, Gamma, Lambda, Delta, Epsilon, and Zeta in Argentina

    Torres C, Mojsiejczuk L, Acuña D, …, Sosa E, …, Fernández Do Porto D, …, Viegas M. Frontiers in Medicine, 2021.

  5. Expression of the tumor-expressed protein MageB2 enhances rRNA transcription

    Ladelfa MF, Peche LY, Amato GE, …, Fernandez Do Porto D, Dardis A, Schneider C. BBA – Molecular Cell Research, 2021.

2020

  1. Prioritization of potential drug targets against Bartonella bacilliformis by an integrative in-silico approach

    Farfán-López M, Espinoza-Culupú A, García-de-la-Guarda R, Serral F, Sosa E, Palomino MM, Fernández Do Porto D. Memórias do Instituto Oswaldo Cruz, 2020.

  2. MRSA dynamic circulation between the community and the hospital setting: new insights from a cohort study in Argentina

    Barcudi D, Sosa EJ, Lamberghini R, …, Fernandez Do Porto DA, …, Turjanski AG, Bocco JL, Sola C. Journal of Infection, 2020.

  3. Methylobacterium sp. 2A Is a Plant Growth-Promoting Rhizobacteria That Has the Potential to Improve Potato Crop Yield Under Adverse Conditions

    Grossi CEM, Fantino E, Serral F, Fernandez Do Porto DA, Ulloa RM. Frontiers in Plant Science, 2020.

  4. El genoma del coronavirus

    Pardo A, Shuster C, Turjanski A, Palomino M, Fernández Do Porto D. Química Viva, 2020.

  5. Strategies to display heterologous proteins on the cell surface of Lactic Acid Bacteria using as anchor the C-terminal domain of Lactobacillus acidophilus SlpA

    Gordillo TB, Palumbo MC, Allievi MC, Fernández Do Porto DA, Ruzal SM, Palomino MM. World Journal of Microbiology and Biotechnology, 2020.

  6. Isolation and Characterization of vB_MsmS_Celfi, M. tuberculosis bacteriophage

    Payaslian F, Gradaschi V, Rondón L, …, Sosa E, Fernández Do Porto D, …, Piuri M. PHAGE: Therapy, Applications, and Research, 2020.

  7. Genome Sequence and Characterization of Lactobacillus casei phage vB_LcaM_Lbab1 isolated from raw milk

    Gradaschi V, Payaslian F, Rondón L, …, Sosa E, Fernández Do Porto D, …, Piuri M. PHAGE: Therapy, Applications, and Research, 2020.

2019

  1. Exploring lectin-like activity of the S-layer protein of Lactobacillus acidophilus ATCC 4356

    Fina Martin J, Palomino MM, Modenutti C, Fernández Do Porto D, Allievi MC, Zanini SH, Cutine A, Mariño K, Barquero A, Ruzal SM., 2019.

  2. Core regulon of the global anaerobic regulator Anr targets central metabolism functions in Pseudomonas species

    Tribelli PM, Lujan A, Pardo A, Ibarra JG, Fernández Do Porto D, Smania A, López NI. Scientific Reports, 2019.

2018

  1. Target-Pathogen: A structural bioinformatic approach to prioritize drug targets in pathogens

    Sosa EJ, Burguener G, Lanzarotti E, Defelipe L, Radusky L, Pardo AM, Marti M, Turjanski AG, Fernández Do Porto D. Nucleic Acids Research, 2018.

  2. An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets

    Pereira Ramos PI, Fernández Do Porto D, Lanzarotti E, Sosa EJ, …, Marti M, Turjanski AG, Nicolás MF. Scientific Reports, 2018.

  3. Fluoromycobacteriophages can determine phenotypic rifampicin resistance of Mycobacterium tuberculosis in just 3-5 days from sputum sample taking

    Rondón L, Urdániz E, Latini C, Matteo M, Sosa E, Fernández Do Porto D, Turjanski A, Nemirovsky S, Hatfull GF, Poggi S, Piuri M. Frontiers in Microbiology, 2018.

2017

  1. Single nucleotide polymorphisms may explain the contrasting phenotypes of two variants of a multidrug-resistant Mycobacterium tuberculosis strain

    Bigi MM, Lopez B, Blanco FC, Sasiain MD, De la Barrera S, Marti MA, Sosa EJ, Fernández Do Porto DA, Ritacco V, Bigi F, Soria MA. Tuberculosis, 2017.

  2. Draft Genome of Lactobacillus helveticus ATCC 12046

    Palomino MM, Burguener G, Campos J, Allievi M, Fina Martin J, Fernandez Do Porto D, Ruzal S. Genome Announcements, 2017.

2016

  1. A whole genome bioinformatic approach to determine potential latent phase specific targets in Mycobacterium tuberculosis

    Defelipe LA, Do Porto DF, Pereira Ramos PI, Nicolás MF, Sosa E, Radusky L, Lanzarotti E, Turjanski AG, Marti MA. Tuberculosis, 2016.

2014

  1. Draft Genome Sequence of the Polyextremophilic Halorubrum sp. Strain AJ67, Isolated from Hyperarsenic Lakes in the Argentinian Puna

    Burguener GF, Maldonado MJ, Revale S, Fernández Do Porto D, Rascován N, Vázquez M, Farías ME, Marti MA, Turjanski AG. Genome Announcements, 2014.

2013

2012

  1. CD137 differentially regulates innate and adaptive immunity against Mycobacterium tuberculosis

    Fernández Do Porto DA, Jurado JO, Pasquinelli V, Alvarez IB, Aspera RH, Musella RM, García VE. Immunology and Cell Biology, 2012.

  2. Achieving maximal speed of solution exchange for patch clamp experiments

    Auzmendi J, Fernández Do Porto D, Moffatt L. PLOS ONE, 2012.

2007

  1. Leptin in embryos from control and diabetic rats during organogenesis: a modulator of nitric oxide production and lipid homeostasis

    White V, Gonzalez E, Pustovrh C, Capobianco E, Martinez N, Do Porto DF, Higa R, Jawerbaum A. Diabetes/Metabolism Research and Reviews, 2007.

Libros y capítulos

  1. Structure-Based Drug Design

    Martí M, Turjanski A, Fernández Do Porto D. Springer, 2024 (libro).

  2. Integrating Omics Data to Prioritize Target Genes in Pathogenic Bacteria

    Nicolás MF, e Costa MOC, Ramos PIP, dos Santos MT, Perez-Rueda E, Marti MA, Fernandez Do Porto D, Turjanski AG. Networks in Systems Biology: Applications on Disease Modeling. Springer, 2020 (capítulo).

  3. Bioinformatic approaches to identify and prioritize targets in pathogenic bacteria

    Palumbo M, Serral F, Turjanski A, Fernández Do Porto D. Bacterial Enzymes as Targets for Drug Discovery: Meeting the Challenges of Antibiotic Resistance. Elsevier (capítulo).

  4. From Genome to Drugs: New Approaches in Antimicrobial Discovery

    Serral F, Castello FA, Sosa EJ, …, Martí MA, Fernández Do Porto D. Pharmacogenetics and Pharmacogenomics in Latin America. Frontiers (capítulo).

  5. Pathway-driven target selection in carbapenem-resistant Klebsiella pneumoniae

    Serral F, Pardo A, Sosa EJ, …, Pereira Ramos PI, Fernández Do Porto D. The Global Threat of Carbapenem-Resistant Gram-Negative Bacteria. Frontiers (capítulo).

  6. Inmunidad antibacteriana

    García V, Pasquinelli V, Jurado J, Alvarez I, Fernández Do Porto D. Introducción a la Inmunología Humana (Fainboim-Geffner), 6.ª edición (capítulo).

  7. Phylogenomic insights into LA-MRSA from Argentine pig farm environments…

    González MJ, Parada J, Blasko E, …, Fernández Do Porto D, …, Zervos M, Sola C. Integrative Microbial and Chemical Genomics to Decipher Antibiotic Resistance Mechanisms and Developing Innovative Antimicrobial Approaches. Frontiers Media SA, 2026 (capítulo).